Skip to content

4547.T

KISSEI PHARMACEUTICAL CO.,LTD.

プライム · 医薬品 · 医薬品 · JP

JPY 3,715.00
−1.72%
Ask drillr

Year over year

Reported trailing growth

Revenue
+10.3%
EBITDA
—
EBIT
—
EPS
+21.4%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
-2.0%
EBITDA
—
EPS
-7.5%

Three-year CAGR

Revenue
+13.0%
EBITDA
-16.8%
EBIT
—
Net income
+9.4%
EPS
+13.2%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026